Pharmacological activity of Guarana (Paullinia cupana Mart.) in laboratory animals
by
Espinola EB, Dias RF, Mattei R, Carlini EA.
Laboratorio de Tecnologia Farmaceutica,
Universidade Federal da Paraiba, Brazil.
J Ethnopharmacol. 1997 Feb;55(3):223-9

ABSTRACT

Mice that ingested a suspension of guarana (Paullinia cupana, Sapindaceae) in a dose of 0.3 mg/ml showed a significant increase in physical capacity when subjected to a stressful situation such as forced swimming after 100 and 200 days of treatment. Such an effect, however, was not obtained with a concentration of 3.0 mg/ml, nor with the ingestion of a suspension of ginseng 5.0 mg/ml, nor of a solution of caffeine 0.1 mg/ml. Guarana, both after a single (3.0 and 30 mg/kg) or chronic administrations (0.3 mg/ml), was able to partially reverse the amnesic effect of scopolamine as measured through a passive avoidance test in mice and rats, indicating a positive effect on memory acquisition. However, no effect was observed when an active avoidance task was used in rats, even after 20 days of guarana administration. There was also a tendency of rats treated with 0.3 mg/ml of guarana to better maintain the memory of a Lashley III maze path. The animals had the same average lifespan, indicating a low toxicity of guarana, even after 23 months of treatment.

Guarana
Paullinia
Nutraceuticals
Nutrigenomics
Iron deficiency
DL-phenylalanine
Calcium and mood
Vitamins and mood
The science of dieting
Docosahexaenoic acid
Catecholamine depletion
Bad moods and sick hearts
Ascorbic acid, mood, and sex
Functional foods and the GI tract

Refs
HOME
HedWeb
HerbWeb
BLTC Research
Utopian Surgery?
The Good Drug Guide
The Hedonistic Imperative
MDMA/Ecstasy: Utopian Pharmacology